Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and

Chhagan Bihari1, Anupama Patil1, Saggere Muralikrishna Shasthry2

  • 1Department of Pathology and Hematology, Institute of Liver and Biliary Sciences, D1, Vasant Kunj, New Delhi, India.

Insights

A new viscoelasticity-based bleeding risk score using activated clotting time (ACT), platelet function (PF), and fibrinogen effectively predicts coagulopathic bleeding in decompensated cirrhosis (DC) patients.

Area of Science:

  • Hepatology
  • Coagulation Science
  • Medical Diagnostics

Background:

  • Predicting coagulopathic bleeding in decompensated cirrhosis (DC) is challenging with conventional assays.
  • Viscoelastic tests (VETs) offer a more comprehensive assessment of coagulation status.
  • The Sonoclot VET was evaluated for its utility in predicting bleeding events.

Purpose of the Study:

  • To investigate the predictive value of Sonoclot VET parameters and fibrinogen for coagulopathic bleeding in DC patients.
  • To develop and validate a bleeding risk score for DC patients.
  • To assess the score's utility in acute-on-chronic liver failure (ACLF) and its correlation with mortality.

Main Methods:

  • Coagulation parameters were measured in 874 patients (compensated cirrhosis, DC, ACLF) and 190 controls.
  • Sonoclot variables (ACT, CR, PF, TP, PA) and fibrinogen levels were analyzed.
  • A bleeding risk score was developed using Cox regression in a derivation cohort and validated in a separate cohort.

Main Results:

  • DC patients exhibited significantly prolonged ACT, longer TP, and smaller PA compared to controls.
  • A bleeding risk score incorporating ACT, PF, and fibrinogen accurately predicted coagulopathic bleeding in both derivation and validation cohorts.
  • The score was also predictive in ACLF patients, and higher scores correlated with increased 1-year mortality due to bleeding.

Conclusions:

  • A viscoelasticity-based bleeding risk score using ACT, PF, and fibrinogen effectively predicts coagulopathic bleeding in DC patients.
  • This score can aid in the rational transfusion of blood products.
  • The developed score is valuable for predicting bleeding complications in advanced liver disease.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
299
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
150
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K